Safety and efficacy of DOACs for non-cirrhotic splanchnic vein thrombosis: a single centre retrospective analysis

Key Points

• Efficacy of direct oral anticoagulants (DOACs) was confirmed for treating non-cirrhotic splanchnic vein thrombosis, enhancing patient care.
• In this analysis, 75% of patients experienced resolution of thrombosis after three months of DOAC treatment.
• Retrospective analysis highlighted safety outcomes, with minimal bleeding events reported among patients treated with DOACs.
• These findings suggest that DOACs may provide an effective and safe option for managing splanchnic vein thrombosis.